Literature DB >> 16049560

Clinical implications of biofilm formation by Enterococcus faecalis in the urinary tract.

Yuko Seno1, Reiko Kariyama, Ritsuko Mitsuhata, Koichi Monden, Hiromi Kumon.   

Abstract

The potential relationships between biofilm formation and pathogenicity of Enterococcus faecalis in urinary tract infections (UTI) were investigated. Over a 12-year period from 1991 through 2002, a total of 352 E.faecalis isolates were collected from patients with complicated UTI (one isolate per patient) at the urology ward of Okayama University Hospital. We analyzed the prevalence and transferability of genes encoding virulence factors(asa1, esp, cylA, gelE /sprE )and antimicrobial resistance(aac(6') /aph(2'')). The production of biofilm, hemolysin and gelatinase by these isolates was also examined and the associated medical records of patients were retrospectively reviewed. Of 352 E. faecalis isolates, 315 possessed and/or genes. Of the 63 hemolysin- and 167 gelatinase-producing isolates, 59 and 94 isolates, respectively, possessed both asa1 and esp genes. E. faecalis isolates with both asa1 and esp genes formed biofilms at significantly higher rates than those with neither gene (P=0.038). The genes encoding asa1, cylA , and aac(6') /(aph(2'') were transferable and appeared to have accumulated in these isolates. The E. faecalis isolates possessing asa1 and/or esp genes were found from both catheter-related or -unrelated UTI. Our study indicates that E. faecalis isolates that have accumulated virulence genes are apt to form persistent biofilms in the urinary tracts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049560     DOI: 10.18926/AMO/31979

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  28 in total

1.  Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.

Authors:  Florian M E Wagenlehner; Martina Kinzig-Schippers; Uwe Tischmeyer; Christine Wagenlehner; Fritz Sörgel; Kurt G Naber
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

Review 2.  Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.

Authors:  Florian M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Enterococcus faecalis from patients with chronic periodontitis: virulence and antimicrobial resistance traits and determinants.

Authors:  J Sun; A Sundsfjord; X Song
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-10       Impact factor: 3.267

4.  Detection and characterization of a ST6 clone of vanB2-Enterococcus faecalis from three different hospitals in Spain.

Authors:  M López; A Rezusta; C Seral; C Aspiroz; C Marne; M J Aldea; I Ferrer; M J Revillo; F J Castillo; C Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-31       Impact factor: 3.267

Review 5.  Probiotics to prevent urinary tract infections: the rationale and evidence.

Authors:  Gregor Reid; Andrew W Bruce
Journal:  World J Urol       Date:  2005-12-31       Impact factor: 4.226

6.  A comparison of monomicrobial versus polymicrobial Enterococcus faecalis bacteriuria in a French University Hospital.

Authors:  C Fourcade; L Canini; J-P Lavigne; A Sotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-19       Impact factor: 3.267

7.  Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections.

Authors:  Pascale S Guiton; Chia S Hung; Lynn E Hancock; Michael G Caparon; Scott J Hultgren
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

8.  Siamycin attenuates fsr quorum sensing mediated by a gelatinase biosynthesis-activating pheromone in Enterococcus faecalis.

Authors:  Jiro Nakayama; Emi Tanaka; Reiko Kariyama; Koji Nagata; Kenzo Nishiguchi; Ritsuko Mitsuhata; Yumi Uemura; Masaru Tanokura; Hiromi Kumon; Kenji Sonomoto
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

9.  The human microbiome and probiotics: implications for pediatrics.

Authors:  Michael H Hsieh; James Versalovic
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2008 Nov-Dec

10.  SalB inactivation modulates culture supernatant exoproteins and affects autolysis and viability in Enterococcus faecalis OG1RF.

Authors:  Jayendra Shankar; Rachel G Walker; Mark C Wilkinson; Deborah Ward; Malcolm J Horsburgh
Journal:  J Bacteriol       Date:  2012-05-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.